Core Points - Waldencast plc has sold its rights to the "Obagi" trademark in Japan to Rohto Pharmaceutical Co., Ltd. for USD $82.5 million [1] - The transaction is part of Waldencast's strategy to improve its capital structure and maximize shareholder value [5][6] Financial Transactions - Rohto has been licensing the "Obagi" mark since 2002, and royalties from this arrangement accounted for 3% of net revenue for the Obagi Medical business for the fiscal year ended December 31, 2024 [2] - Waldencast has entered into a new credit agreement with Lumina Capital Management for a secured first-lien term loan facility of $225 million, aimed at improving liquidity and supporting brand growth [3][4] - Proceeds from the sale to Rohto will be used to repay a significant portion of the new loan facility, further deleveraging the company's balance sheet [4] Strategic Focus - The company is currently reviewing a range of strategic alternatives to enhance shareholder value, with the recent transactions reflecting this ongoing focus [5] - The CEO of Waldencast expressed that these transactions will substantially strengthen the company's balance sheet while exploring strategic options [6]

Core Points - President Trump has exempted key agricultural imports from higher tariff rates, including coffee, cocoa, bananas, and certain beef products [1][2] - This decision comes in response to political pressure due to rising grocery prices linked to tariffs and high inflation [2] - The exemptions also include a variety of fruits and other food items, marking a significant policy shift from Trump's previous stance on tariffs [3] Agricultural Imports - Key agricultural imports exempted from tariffs include coffee, cocoa, bananas, and certain beef products [1] - Additional exemptions cover fruits such as tomatoes, avocados, coconuts, oranges, and pineapples, as well as black and green tea, and spices like cinnamon and nutmeg [3] Economic Context - The tariff exemptions are a response to increased prices for common food items, which have been exacerbated by Trump's tariffs and high inflation rates [2] - Trump's previous insistence on tariffs being necessary for protecting U.S. businesses and workers is contradicted by this recent policy change [3]

Core Insights - Centene Corporation's shares have increased by 6.2% from their recent low of $34.25 on November 10 [1] Company Summary - The stock price of Centene Corporation (NYSE: CNC) has shown a positive movement, indicating potential recovery or investor confidence [1]

: Millions of Americans are living on the edge, spending nearly all their income just to cover basic necessities like housing, groceries, and utilities, as per a report. A new Bank of America Institute analysis found that 24% of US households in 2025 are living paycheck to paycheck, leaving little room for savings, vacations, or unexpected expenses, as per a CNN report.Nearly 1 in 4 US Households Living Paycheck to Paycheck in 2025The study found that nearly a quarter of households spend over 95% of their ...

Core Viewpoint - The current market environment is characterized by a potential unwinding of momentum trades, particularly in AI, and uncertainty surrounding the Federal Reserve's actions, which may lead to volatility and adjustments in valuations [1][2][4]. Market Rotation and Economic Outlook - There is a noticeable rotation in the market, with concerns about the Federal Reserve's decisions impacting investor sentiment. Despite this, there remains a pro-risk stance, particularly towards equities [2][4]. - Earnings growth for the MAG 7 is expected to slow from 18% in Q4 of this year to 14% next year, while the broader market (the forgotten 493) is projected to grow from 2% in Q4 to 15% next year, indicating a broadening market [3]. Earnings Projections and Investment Strategy - Earnings for the S&P 500 are anticipated to increase by approximately 13% in 2026 and over 14% in 2027, with technology leading this growth [6]. - Investors are advised to view potential declines as buying opportunities, with historical data suggesting that pullbacks of 5% to 10% typically recover quickly [13]. Asset Allocation and Hedge Funds - There is a recommendation to consider hedge funds as part of a global asset allocation strategy, especially in a slowing economy, as they tend to perform well under such conditions [8]. - The focus on global AI developments is emphasized, particularly in emerging markets, which presents additional investment opportunities [9]. Investment Approach for Retail Investors - Retail investors are encouraged to maintain a long-term perspective, focusing on buying and holding equities rather than engaging in high-risk strategies like margin trading [12]. - It is suggested that investors should rotate into sectors showing relative strength, such as pure value over pure growth within the S&P 500 [14].

Presentation Unknown Attendee So our final panel of the day is about vaccines. Everyone, if we could please quiet down, if you don't mind. Thank you. So our final panel today is on vaccine access and development. I'm joined here by my colleague, research analyst, Elena Meng from Gabelli Funds; Michelle Kehily, VP U.S. Pediatric and Pipeline Vaccines at Merck; Dr. Stephen Morse, Professor of Epidemiology at Columbia Mailman School of Public Health; Michael Paas, VP, Head of Value & Access at AbbVie; and fi ...

NEW YORK--(BUSINESS WIRE)--iHeartMedia announced that the annual station flip to holiday music has kicked off this month and more than 95 stations across the country will broadcast the season's festive music from today's biggest artists as well as Christmas classics from Bing Crosby, Dean Martin, Frank Sinatra and more, 24/7. Continuing the celebration of the holiday season, the iHeartRadio Holiday Special returns this year hosted by Mario Lopez. The broadcast will feature interviews with Goo G. ...

–Fast Track Designation was granted for BB-301 following U.S. Food and Drug Administration (FDA) review of positive interim clinical study results and proprietary Responder Analysis planned for use in pivotal study for BB-301– –Positive interim clinical study results from the Phase 1b/2a trial of BB-301, showed a 100% responder rate, with all six patients in Cohort 1 meeting the formal statistical criteria for response to BB-301– –First patient of Cohort 2 successfully treated with BB-301 in Q4 of 2025– –Th ...

PHILADELPHIA, Miss.--(BUSINESS WIRE)--Citizens Holding Company (the "Company†) (OTCQX:CIZN) today announced that Stacy Brantley, Chief Executive Officer, and Vincent Craig Dungan, Director have recently purchased common stock in CIZN. As required by the Company's insider trading policy, the purchases and total beneficial ownership after the purchases are listed below: Name Title of Security Securities Acquired Amount Price Amount of Securities Beneficially Owned Following Reported Transaction O. ...

Data from Phase 2 BESTOW trial demonstrated a favorable safety and tolerability profile, substantially reducing the metabolic, neurologic, and cardiovascular toxicities commonly associated with tacrolimus  Data supports advancement into Phase 3 development as a potential new standard for the prevention of kidney transplant rejection Strengthened balance sheet with $57.5 million financing to advance transplantation programs IRVINE, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eled ...